.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Ayurveda startup acquisitions are rapidly reshaping India’s consumer goods landscape. Major FMCG players now target regional and niche brands to drive growth during broader market slowdowns. For instance, Emami recently announced its acquisition of a 100% stake in Axiom Ayurveda. This deal, valued at up to Rs 200 crore, brings the popular AloFrut brand under Emami's umbrella. Furthermore, the move allows Emami to enter the fast-growing health beverage segment effectively.
Dabur India is also expanding its footprint through strategic investments. Last month, the company acquired a 51% stake in RAS Luxury Oils for approximately Rs 110-120 crore. This acquisition marks Dabur’s entry into the premium ayurvedic skincare market. Notably, Reliance Retail recently purchased Himachal-based Pahadi Local to strengthen its wellness portfolio. These strategic moves highlight a shift toward premium, digitally native brands that appeal to new-age consumers.
International interest in Indian heritage brands is reaching new heights. Estee Lauder Companies is currently moving to fully acquire Forest Essentials. This deal carries an estimated valuation between Rs 5,800 and Rs 6,600 crore. Consequently, the global market recognizes the value of India's ayurveda-led formulations. Many consumers now prefer specialized products rooted in nature over chemical-heavy alternatives.
Despite the rising interest, herbal healthcare penetration remains low in India. Currently, it accounts for less than 5% of the overall healthcare market. In contrast, China’s herbal market penetration stands at approximately 15%. This disparity suggests significant room for growth within the Indian ecosystem. Therefore, investors view categories like diabetic care and premium skincare as high-potential sectors. Industry experts predict more Ayurveda startup acquisitions in the premium beauty and personal care categories over the next 18 months.
Q1: Why are FMCG companies increasingly acquiring Ayurveda startups?
FMCG majors face stagnant volume growth in traditional categories. By acquiring niche Ayurveda brands, they gain access to premium, high-growth segments and new-age consumers who prefer natural, sustainable products.
Q2: How does India’s herbal healthcare market compare to China?
India’s herbal healthcare market currently has less than 5% penetration. This is significantly lower than China’s 15% penetration, indicating a massive untapped opportunity for growth in the Indian market.
Q3: What role does digital-native branding play in these acquisitions?
Many targeted startups are digitally native, meaning they have strong online presences. FMCG giants use these acquisitions to acquire tech-savvy consumer bases and modern brand identities that complement their traditional portfolios.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Major FMCG companies are acquiring niche Ayurveda brands to drive growth, targeting premium skincare, herbal juices, and new-age digital consumers....
6 months ago
Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today
A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today
The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today
Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today
India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today
